This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
artificial-intelligence: Archive
IBM's Neudesic Boosts Cloud Security Capabilities: An Ace Up Sleeve?
by Supriyo Bose
Neudesic renews Microsoft Cloud Security Specialization, reinforcing IBM's push into hybrid, multi-cloud security solutions.
MSFTNegative Net Change IBMPositive Net Change CDWNegative Net Change RBRKPositive Net Change
artificial-intelligence cloud-computing communications computers iot tech-stocks
Should You Buy WisdomTree, Inc. (WT) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
WTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Vertiv Holdings Co. (VRT)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
VRTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy WSFS Financial (WSFS) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
WSFSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy 1st Source (SRCE) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SRCENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
MSC Industrial (MSM)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
MSMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend?
by Indrajit Bandyopadhyay
OPRX raised guidance after record Q1 EBITDA, but pharma budget shifts and margin mix pose new challenges ahead.
OPRXNegative Net Change VEEVPositive Net Change HCATNegative Net Change
artificial-intelligence computers medical
Tempus AI Revenues & Profit Rise: What to Expect Ahead of Q2 Release
by Urmimala Biswas
TEM's revenue and gross profit are climbing fast as new AI tools and data services boost margins ahead of Q2 earnings.
NTRAPositive Net Change GHNegative Net Change TEMPositive Net Change
artificial-intelligence medical medical-devices smart-health
The Next Leg Up Has Just Begun: Why I'm Expecting A 20% Gain Over The Next 6 Months
by Kevin Matras
After rebounding from steep losses to new highs in just three short months, the stock market is setting the stage for another double-digit gain in 2025. Kevin Matras outlines his strategy for making the most of this powerful rebound.
NTRAPositive Net Change GHNegative Net Change TEMPositive Net Change
artificial-intelligence earnings
Better AI Stock for 2H25: NVIDIA or Palantir?
by Tirthankar Chakraborty
PLTR has surged 74.7% YTD, topping NVDA's 17.1% - but can it keep outperforming in the AI race despite its lofty valuation?
AMZNPositive Net Change MSFTNegative Net Change NVDANegative Net Change GOOGLPositive Net Change PLTRNegative Net Change
artificial-intelligence magnificent-7 semiconductor tech-stocks
Top AI Stocks to Add to Your Portfolio for Impressive Returns
by Aniruddha Ganguly
Here, we have picked three AI stocks, DELL, ADBE and MSFT, which are well poised to benefit from AI's growing usage and ability to solve complex problems.
MSFTNegative Net Change DELLNegative Net Change NVDANegative Net Change ADBEPositive Net Change GOOGLPositive Net Change METAPositive Net Change
artificial-intelligence tech-stocks
What Makes Atlas the Core Driver of MongoDB's Revenue Growth?
by Zacks Equity Research
Atlas drives 72% of MDB's revenues as strong adoption boosts customer growth and underpins raised fiscal 2026 guidance.
AMZNPositive Net Change MDBPositive Net Change BASEPositive Net Change
artificial-intelligence tech-stocks
ROKU vs. DIS: Which Ad-Supported Streaming Stock is the Better Pick?
by Akashlina Dewanjee
DIS leverages ESPN, Hulu and rising engagement to outshine ROKU's ad-tech gains in the race for streaming ad dollars.
DISNegative Net Change ROKUPositive Net Change
ad-tech advertising artificial-intelligence consumer-discretionary
3 IT Services Stocks to Buy Right Now From a Prospering Industry
by Aniruddha Ganguly
The Zacks Computers - IT Services Industry participants like INFY, CTSH and TBLA are benefiting from ongoing digitization, strong demand for hybrid working solutions and improving IT spending.
INFYPositive Net Change CTSHPositive Net Change TBLAPositive Net Change
artificial-intelligence tech-stocks
QCOM Shares Gain 28.2% in Three Months: How to Play the Stock?
by Aritra Chatterjee
Qualcomm jumps 28.2% in three months on strong chip demand and innovation, but faces stiff competition and estimate cuts.
INTCPositive Net Change QCOMNegative Net Change AVGONegative Net Change
artificial-intelligence communications tech-stocks
AMD vs. Micron Technology: Which Semiconductor Stock Has More Upside?
by Nilanshi Mukherjee
MU's surging HBM demand, stronger earnings growth, and better valuation metrics may give it an edge over Advanced Micro Devices.
AMDNegative Net Change MUNegative Net Change
artificial-intelligence semiconductor tech-stocks
Weekly Option Windfall: Snowflake Call Spread Boasts 31% Profit Potential
by Bryan Hayes
Option spreads can be profitable even if the underlying stock decreases or remains flat.
SNOWPositive Net Change
artificial-intelligence automation cloud-computing earnings options software tech-stocks
OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock?
by Indrajit Bandyopadhyay
OPRX surged 69.3% in three months as rising contracted revenue and subscription gains boost confidence and guidance.
OPRXNegative Net Change TDOCPositive Net Change DOCSPositive Net Change
artificial-intelligence computers
Should You Buy Hancock Whitney (HWC) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
HWCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Ionis Pharmaceuticals (IONS) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
IONSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
UBS (UBS)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
UBSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
IBM Concert Gains Traction: Can This AI-Driven Solution Aid the Stock?
by Supriyo Bose
IBM Concert lands Deutsche Telekom as a client, showcasing how AI automation could reshape hybrid cloud security.
AMZNPositive Net Change MSFTNegative Net Change IBMPositive Net Change DTEGYPositive Net Change
artificial-intelligence cloud-computing communications computers cybersecurity iot software tech-stocks
TSM Stock Hits 52-Week High: Is It Time to Book Profits or Buy More?
by Anirudha Bhagat
Taiwan Semiconductor hits a 52-week high as AI chip demand surges, earnings soar, and valuation still leaves room for upside.
INTCPositive Net Change AMDNegative Net Change NVDANegative Net Change TSMNegative Net Change
artificial-intelligence computers semiconductor tech-stocks
5 Momentum Picks for Third-Quarter 2025 After a Stellar Second Quarter
by Nalak Das
JBL, NEM, HEI, ROK and EL are riding strong Q3 momentum after U.S. stocks posted their best quarter in over a year.
ELPositive Net Change NEMPositive Net Change ROKNegative Net Change JBLNegative Net Change HEINegative Net Change
aerospace artificial-intelligence consumer-staples gold tech-stocks
Bull of the Day: Rockwell Automation, Inc. (ROK)
by Benjamin Rains
ROK is on the verge of breaking out of a trading range it's been stuck in since 2021, as Wall Street looks ahead to strong earnings growth and long-term upside in an increasingly automated manufacturing economy.
NVDANegative Net Change ROKNegative Net Change
artificial-intelligence tech-stocks